TNF and psoriasis: The TNF-308 rs1800629 polymorphism is the one with the strongest evidence; it has been extensively studied in patients treated with biologic drugs, specifically etanercept, and diagnosed with autoimmune conditions such as psoriasis, rheumatoid arthritis, and Crohn’s disease, showing moderate evidence (level 2B).